TN2013000080A1 - Quinoline and quinoxaline derivalives as kinase inhibitors - Google Patents

Quinoline and quinoxaline derivalives as kinase inhibitors

Info

Publication number
TN2013000080A1
TN2013000080A1 TNP2013000080A TN2013000080A TN2013000080A1 TN 2013000080 A1 TN2013000080 A1 TN 2013000080A1 TN P2013000080 A TNP2013000080 A TN P2013000080A TN 2013000080 A TN2013000080 A TN 2013000080A TN 2013000080 A1 TN2013000080 A1 TN 2013000080A1
Authority
TN
Tunisia
Prior art keywords
quinoline
quinoxaline
derivalives
kinase inhibitors
oncological
Prior art date
Application number
TNP2013000080A
Other languages
French (fr)
Inventor
Andrew Harry Parton
Mezher Hussein Ali
Daniel Christopher Brookings
Julien Alistair Brown
Daniel James Ford
Richard Jeremy Franklin
Barry John Langham
Judi Charlotte Neuss
Joanna Rachel Quincey
Original Assignee
Ucb Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2011/051647 external-priority patent/WO2012032334A1/en
Application filed by Ucb Pharma Sa filed Critical Ucb Pharma Sa
Publication of TN2013000080A1 publication Critical patent/TN2013000080A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A series of quinoline and quinoxaline derivatives comprising a fluorinated ethyl side-chain, being selective inhibitors of P13 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.
TNP2013000080A 2011-09-02 2013-02-28 Quinoline and quinoxaline derivalives as kinase inhibitors TN2013000080A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB2011/051647 WO2012032334A1 (en) 2010-09-08 2011-09-02 Quinoline and quinoxaline derivatives as kinase inhibitors

Publications (1)

Publication Number Publication Date
TN2013000080A1 true TN2013000080A1 (en) 2014-06-25

Family

ID=54360773

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000080A TN2013000080A1 (en) 2011-09-02 2013-02-28 Quinoline and quinoxaline derivalives as kinase inhibitors

Country Status (1)

Country Link
TN (1) TN2013000080A1 (en)

Similar Documents

Publication Publication Date Title
MY162396A (en) Quinoline and quinoxaline derivatives as kinase inhibitors
WO2009081105A3 (en) Quinoxaline and quinoline derivatives as kinase inhibitors
EP4052681A3 (en) Accommodating intraocular lenses and methods of use
AP3893A (en) Operating method of terminal based on multiple inputs and portable terminal supporting the same
EP2818543A4 (en) Bacillus, hyaluronic acid enzyme, and uses thereof
WO2012129084A3 (en) Glucosylceramide synthase inhibitors
MX2016001037A (en) Inhibitors of transcription factors and uses thereof.
MX355728B (en) Kinase inhibitors.
HUE058058T2 (en) Alpha-amylase variants derived from the alpha amylase of cytophaga sp. amylasei(cspamy2).
WO2012104007A3 (en) 7-azaindole derivatives
WO2010052448A3 (en) Fused pyrazine derivatives as kinase inhibitors
IL226114B (en) Oplophorus-derived luciferases, novel coelenterazine substrates and methods of use
WO2012006616A3 (en) Intraocular lens delivery devices and methods of use
WO2013083999A3 (en) Nano-enhanced elastomers
GB201214727D0 (en) Golf coupling mechanisms and related methods
MX2013009175A (en) Compositions comprising peroxy î±-ketocarboxylic acid and methods for producing and using the same.
IN2014DN08481A (en)
WO2012125544A3 (en) Necroptosis inhibitors and methods of use therefor
EP3822352A3 (en) Methods and compositions for modulating apolipoprotein(a) expression
WO2013188469A3 (en) Pathways characterization of cells
GB201214733D0 (en) Golf coupling mechanisms and related methods
AU2013225816A8 (en) Compositions and methods for treating Type III Gaucher Disease
WO2013106273A3 (en) Peptides and methods of using same
GB2519697A (en) Golf fitting systems and related methods
WO2013040251A3 (en) Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease